These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 23160303)
1. The entire predictive value of the prometheus IBD sgi diagnostic product may be due to the three least expensive and most available components. Shirts B; von Roon AC; Tebo AE Am J Gastroenterol; 2012 Nov; 107(11):1760-1. PubMed ID: 23160303 [No Abstract] [Full Text] [Related]
2. Use of serologic markers as a screening tool in inflammatory bowel disease compared with elevated erythrocyte sedimentation rate and anemia. Sabery N; Bass D Pediatrics; 2007 Jan; 119(1):e193-9. PubMed ID: 17158948 [TBL] [Abstract][Full Text] [Related]
3. The IBD SGI Diagnostic Test Is Frequently Used by Non-gastroenterologists to Screen for Inflammatory Bowel Disease. Berinstein JA; Waljee AK; Stidham RW; Higgins PDR; Govani SM Inflamm Bowel Dis; 2018 Apr; 24(5):e18. PubMed ID: 29688480 [No Abstract] [Full Text] [Related]
6. Faecal lactoferrin--a novel test to differentiate between the irritable and inflamed bowel? Sidhu R; Wilson P; Wright A; Yau CW; D'Cruz FA; Foye L; Morley S; Lobo AJ; McAlindon ME; Sanders DS Aliment Pharmacol Ther; 2010 Jun; 31(12):1365-70. PubMed ID: 20331581 [TBL] [Abstract][Full Text] [Related]
7. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease]. van den Bergh FA; Kolkman JJ; Russel MG; Vlaskamp RT; Vermes I Ned Tijdschr Geneeskd; 2003 Nov; 147(48):2360-5. PubMed ID: 14677476 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. von Roon AC; Karamountzos L; Purkayastha S; Reese GE; Darzi AW; Teare JP; Paraskeva P; Tekkis PP Am J Gastroenterol; 2007 Apr; 102(4):803-13. PubMed ID: 17324124 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Bansi DS; Chapman RW; Fleming KA Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455 [TBL] [Abstract][Full Text] [Related]
13. Shortcomings of the inflammatory bowel disease Serology 7 panel. Benor S; Russell GH; Silver M; Israel EJ; Yuan Q; Winter HS Pediatrics; 2010 Jun; 125(6):1230-6. PubMed ID: 20439597 [TBL] [Abstract][Full Text] [Related]
14. Update of fecal markers of inflammation in inflammatory bowel disease. Judd TA; Day AS; Lemberg DA; Turner D; Leach ST J Gastroenterol Hepatol; 2011 Oct; 26(10):1493-9. PubMed ID: 21777275 [TBL] [Abstract][Full Text] [Related]
15. Markers that differentiate early from late IBD. Huang C; Kugathasan S Dig Dis; 2012; 30(4):380-2. PubMed ID: 22796800 [TBL] [Abstract][Full Text] [Related]
16. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Dubinsky MC; Ofman JJ; Urman M; Targan SR; Seidman EG Am J Gastroenterol; 2001 Mar; 96(3):758-65. PubMed ID: 11280547 [TBL] [Abstract][Full Text] [Related]